| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytochrome P-450 CYP3A | 8 | 2015 | 60 | 1.940 |
Why?
|
| Microsomes, Liver | 9 | 2017 | 100 | 1.450 |
Why?
|
| Isoniazid | 4 | 2016 | 66 | 1.370 |
Why?
|
| Antitubercular Agents | 5 | 2016 | 263 | 1.310 |
Why?
|
| Aldehydes | 3 | 2015 | 32 | 1.260 |
Why?
|
| Cytochrome P-450 Enzyme System | 4 | 2017 | 142 | 1.110 |
Why?
|
| Ritonavir | 3 | 2011 | 48 | 1.050 |
Why?
|
| Liver | 9 | 2017 | 1875 | 0.860 |
Why?
|
| HIV Protease Inhibitors | 3 | 2017 | 49 | 0.800 |
Why?
|
| Chemical and Drug Induced Liver Injury | 5 | 2016 | 117 | 0.790 |
Why?
|
| Metabolomics | 12 | 2017 | 456 | 0.770 |
Why?
|
| Pyridines | 2 | 2010 | 247 | 0.600 |
Why?
|
| Quinazolines | 2 | 2017 | 184 | 0.570 |
Why?
|
| Acetaminophen | 4 | 2013 | 100 | 0.540 |
Why?
|
| Receptors, Melatonin | 1 | 2016 | 2 | 0.510 |
Why?
|
| Xenobiotics | 2 | 2018 | 29 | 0.510 |
Why?
|
| Acetamides | 1 | 2016 | 50 | 0.490 |
Why?
|
| Homeostasis | 5 | 2017 | 749 | 0.470 |
Why?
|
| Liver Diseases | 1 | 2019 | 388 | 0.470 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 138 | 0.460 |
Why?
|
| Mice | 28 | 2019 | 18911 | 0.450 |
Why?
|
| Receptors, Steroid | 2 | 2013 | 276 | 0.440 |
Why?
|
| Saquinavir | 1 | 2013 | 5 | 0.440 |
Why?
|
| Metabolome | 3 | 2011 | 312 | 0.400 |
Why?
|
| Rifampin | 1 | 2013 | 134 | 0.380 |
Why?
|
| Lopinavir | 1 | 2011 | 7 | 0.370 |
Why?
|
| Hydrazones | 1 | 2011 | 19 | 0.370 |
Why?
|
| Monoterpenes | 1 | 2011 | 5 | 0.370 |
Why?
|
| Bile Acids and Salts | 6 | 2016 | 259 | 0.360 |
Why?
|
| Hepatocytes | 5 | 2016 | 242 | 0.360 |
Why?
|
| Animals | 31 | 2019 | 36398 | 0.360 |
Why?
|
| Protease Inhibitors | 1 | 2011 | 100 | 0.360 |
Why?
|
| Clozapine | 1 | 2011 | 25 | 0.360 |
Why?
|
| Hydrazines | 1 | 2010 | 34 | 0.350 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 611 | 0.340 |
Why?
|
| Oligopeptides | 1 | 2010 | 122 | 0.340 |
Why?
|
| Cholesterol | 3 | 2019 | 574 | 0.340 |
Why?
|
| Pyrones | 1 | 2010 | 6 | 0.340 |
Why?
|
| Recombinant Proteins | 5 | 2017 | 1439 | 0.330 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2011 | 81 | 0.330 |
Why?
|
| Biotransformation | 3 | 2016 | 55 | 0.320 |
Why?
|
| Glutathione | 3 | 2017 | 201 | 0.320 |
Why?
|
| Feces | 4 | 2016 | 786 | 0.300 |
Why?
|
| Cytochrome P-450 CYP3A Inhibitors | 3 | 2015 | 11 | 0.290 |
Why?
|
| Membrane Proteins | 1 | 2015 | 1607 | 0.280 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2018 | 197 | 0.280 |
Why?
|
| Antipsychotic Agents | 1 | 2011 | 388 | 0.270 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 1850 | 0.260 |
Why?
|
| Mice, Knockout | 7 | 2018 | 3980 | 0.250 |
Why?
|
| Protoporphyrins | 2 | 2016 | 8 | 0.240 |
Why?
|
| Isoenzymes | 2 | 2016 | 231 | 0.240 |
Why?
|
| Atazanavir Sulfate | 2 | 2017 | 6 | 0.230 |
Why?
|
| Carnitine | 2 | 2016 | 77 | 0.230 |
Why?
|
| Oxidation-Reduction | 3 | 2016 | 465 | 0.230 |
Why?
|
| Dealkylation | 3 | 2014 | 4 | 0.220 |
Why?
|
| Liver Regeneration | 2 | 2013 | 40 | 0.210 |
Why?
|
| Drug Overdose | 2 | 2013 | 75 | 0.200 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2018 | 392 | 0.200 |
Why?
|
| Cytochrome P-450 CYP2C8 | 2 | 2014 | 3 | 0.200 |
Why?
|
| Cytochrome P-450 CYP2C19 | 2 | 2014 | 21 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 12 | 2019 | 4821 | 0.190 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 2014 | 44 | 0.190 |
Why?
|
| Molecular Structure | 2 | 2015 | 318 | 0.190 |
Why?
|
| Hydroxylation | 2 | 2011 | 50 | 0.180 |
Why?
|
| Humans | 26 | 2019 | 133932 | 0.170 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2010 | 60 | 0.170 |
Why?
|
| Drug Delivery Systems | 2 | 2018 | 235 | 0.160 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2010 | 364 | 0.160 |
Why?
|
| Mice, Inbred ICR | 2 | 2016 | 153 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2018 | 217 | 0.150 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2018 | 12 | 0.150 |
Why?
|
| Cytochrome P-450 CYP1B1 | 1 | 2018 | 31 | 0.150 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2018 | 41 | 0.150 |
Why?
|
| Gene Expression Regulation | 3 | 2016 | 2656 | 0.150 |
Why?
|
| Butyrates | 1 | 2018 | 42 | 0.150 |
Why?
|
| Glucose | 3 | 2017 | 924 | 0.150 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2018 | 83 | 0.140 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2018 | 30 | 0.140 |
Why?
|
| Naphthalimides | 1 | 2017 | 7 | 0.140 |
Why?
|
| Proglucagon | 1 | 2017 | 5 | 0.140 |
Why?
|
| Response Elements | 1 | 2018 | 106 | 0.140 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2018 | 107 | 0.140 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2018 | 58 | 0.140 |
Why?
|
| Endoribonucleases | 1 | 2018 | 77 | 0.140 |
Why?
|
| Fibronectins | 1 | 2017 | 112 | 0.140 |
Why?
|
| Fluorometry | 1 | 2017 | 26 | 0.140 |
Why?
|
| Signal Transduction | 4 | 2018 | 4900 | 0.140 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2017 | 56 | 0.140 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2017 | 73 | 0.140 |
Why?
|
| Leucine | 1 | 2018 | 313 | 0.130 |
Why?
|
| Phospholipase D | 1 | 2016 | 7 | 0.130 |
Why?
|
| Vitamin B 6 | 1 | 2016 | 10 | 0.130 |
Why?
|
| Cysteamine | 1 | 2016 | 15 | 0.130 |
Why?
|
| Cystinosis | 1 | 2016 | 16 | 0.130 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2016 | 50 | 0.130 |
Why?
|
| Benzimidazoles | 1 | 2017 | 136 | 0.130 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2016 | 31 | 0.130 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2016 | 139 | 0.130 |
Why?
|
| Semicarbazides | 1 | 2016 | 3 | 0.130 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2016 | 35 | 0.130 |
Why?
|
| Male | 16 | 2019 | 65882 | 0.130 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 270 | 0.120 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2015 | 10 | 0.120 |
Why?
|
| Imines | 1 | 2015 | 9 | 0.120 |
Why?
|
| Bufanolides | 1 | 2015 | 17 | 0.120 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2015 | 15 | 0.120 |
Why?
|
| Prodrugs | 1 | 2015 | 62 | 0.120 |
Why?
|
| Glycochenodeoxycholic Acid | 1 | 2015 | 8 | 0.120 |
Why?
|
| Jaundice, Obstructive | 1 | 2015 | 5 | 0.120 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2015 | 7 | 0.120 |
Why?
|
| Macrophages | 1 | 2019 | 704 | 0.120 |
Why?
|
| Swine | 1 | 2018 | 1216 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 2527 | 0.110 |
Why?
|
| Mice, Inbred Strains | 2 | 2017 | 321 | 0.110 |
Why?
|
| Lithocholic Acid | 1 | 2014 | 2 | 0.110 |
Why?
|
| Stress, Physiological | 1 | 2016 | 271 | 0.110 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 139 | 0.110 |
Why?
|
| Fatty Liver | 1 | 2016 | 213 | 0.110 |
Why?
|
| Muscle, Skeletal | 2 | 2018 | 1052 | 0.110 |
Why?
|
| Diarylquinolines | 1 | 2014 | 6 | 0.110 |
Why?
|
| Immunotherapy | 1 | 2019 | 749 | 0.110 |
Why?
|
| ErbB Receptors | 1 | 2015 | 303 | 0.110 |
Why?
|
| Antidotes | 1 | 2013 | 14 | 0.110 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2016 | 315 | 0.110 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2015 | 197 | 0.110 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2015 | 351 | 0.100 |
Why?
|
| Autophagy | 1 | 2016 | 423 | 0.100 |
Why?
|
| Alkaline Phosphatase | 1 | 2013 | 104 | 0.100 |
Why?
|
| Acetylcysteine | 1 | 2013 | 85 | 0.100 |
Why?
|
| Heme | 1 | 2013 | 54 | 0.100 |
Why?
|
| Principal Component Analysis | 2 | 2010 | 160 | 0.100 |
Why?
|
| Alanine Transaminase | 1 | 2013 | 162 | 0.100 |
Why?
|
| Insulin Resistance | 1 | 2017 | 687 | 0.100 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2015 | 267 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2019 | 951 | 0.100 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 426 | 0.090 |
Why?
|
| Mitochondria | 2 | 2016 | 747 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 609 | 0.090 |
Why?
|
| Amino Acids, Essential | 1 | 2011 | 28 | 0.090 |
Why?
|
| Neutrophils | 1 | 2014 | 401 | 0.090 |
Why?
|
| Inflammation | 2 | 2016 | 1599 | 0.090 |
Why?
|
| Atherosclerosis | 1 | 2019 | 999 | 0.090 |
Why?
|
| Cornea | 1 | 2016 | 685 | 0.090 |
Why?
|
| Ketoconazole | 1 | 2010 | 10 | 0.090 |
Why?
|
| Sophora | 1 | 2010 | 1 | 0.090 |
Why?
|
| Kynuramine | 1 | 2010 | 1 | 0.090 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2010 | 24 | 0.090 |
Why?
|
| Kidney | 1 | 2017 | 1410 | 0.090 |
Why?
|
| Cytochrome P-450 CYP2D6 Inhibitors | 1 | 2010 | 3 | 0.080 |
Why?
|
| Animal Structures | 1 | 2010 | 13 | 0.080 |
Why?
|
| Melatonin | 1 | 2010 | 30 | 0.080 |
Why?
|
| Biocatalysis | 1 | 2010 | 36 | 0.080 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2010 | 34 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 1197 | 0.080 |
Why?
|
| Tissue Distribution | 1 | 2010 | 400 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 776 | 0.080 |
Why?
|
| Drug Interactions | 1 | 2010 | 261 | 0.080 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 279 | 0.070 |
Why?
|
| Hep G2 Cells | 2 | 2019 | 97 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2010 | 286 | 0.070 |
Why?
|
| Energy Metabolism | 3 | 2017 | 812 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 607 | 0.070 |
Why?
|
| Antioxidants | 1 | 2010 | 378 | 0.070 |
Why?
|
| Biomarkers | 2 | 2015 | 3423 | 0.070 |
Why?
|
| Anti-HIV Agents | 1 | 2010 | 345 | 0.070 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 4776 | 0.060 |
Why?
|
| Oxygen Consumption | 2 | 2017 | 316 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2016 | 3167 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 2764 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 3751 | 0.060 |
Why?
|
| Mass Spectrometry | 2 | 2016 | 371 | 0.060 |
Why?
|
| Necrosis | 2 | 2015 | 220 | 0.050 |
Why?
|
| Cell Survival | 2 | 2016 | 891 | 0.050 |
Why?
|
| Cell Proliferation | 3 | 2016 | 2539 | 0.050 |
Why?
|
| Lipid Metabolism | 2 | 2016 | 383 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 1735 | 0.050 |
Why?
|
| Neoplasms | 1 | 2016 | 3027 | 0.050 |
Why?
|
| Female | 7 | 2018 | 71659 | 0.040 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2019 | 5 | 0.040 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2019 | 22 | 0.040 |
Why?
|
| THP-1 Cells | 1 | 2019 | 24 | 0.040 |
Why?
|
| Liver X Receptors | 1 | 2019 | 19 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2019 | 45 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2019 | 125 | 0.040 |
Why?
|
| Oxazines | 1 | 2018 | 26 | 0.040 |
Why?
|
| Valerates | 1 | 2018 | 9 | 0.040 |
Why?
|
| Cytochrome P-450 CYP2B6 | 1 | 2018 | 16 | 0.040 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2018 | 83 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 64 | 0.040 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2017 | 44 | 0.040 |
Why?
|
| Cytochromes | 1 | 2017 | 7 | 0.040 |
Why?
|
| Pyridones | 1 | 2018 | 125 | 0.040 |
Why?
|
| Receptors, Glucagon | 1 | 2017 | 30 | 0.040 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2017 | 41 | 0.030 |
Why?
|
| Kidney Tubules | 1 | 2017 | 78 | 0.030 |
Why?
|
| Transfection | 1 | 2019 | 1089 | 0.030 |
Why?
|
| Chimera | 1 | 2017 | 88 | 0.030 |
Why?
|
| Glucagon | 1 | 2017 | 184 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 106 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2017 | 139 | 0.030 |
Why?
|
| Alkalies | 1 | 2016 | 25 | 0.030 |
Why?
|
| Membrane Lipids | 1 | 2016 | 35 | 0.030 |
Why?
|
| Cystine | 1 | 2016 | 17 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2017 | 224 | 0.030 |
Why?
|
| Piperazines | 1 | 2018 | 257 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 295 | 0.030 |
Why?
|
| Physical Conditioning, Animal | 1 | 2017 | 100 | 0.030 |
Why?
|
| Exhalation | 1 | 2016 | 12 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2013 | 2903 | 0.030 |
Why?
|
| Lipid Droplets | 1 | 2016 | 48 | 0.030 |
Why?
|
| Ophthalmic Solutions | 1 | 2016 | 94 | 0.030 |
Why?
|
| Phospholipids | 1 | 2016 | 113 | 0.030 |
Why?
|
| Fibrosis | 1 | 2017 | 461 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2017 | 828 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 450 | 0.030 |
Why?
|
| Keratin-18 | 1 | 2015 | 7 | 0.030 |
Why?
|
| Kinetics | 1 | 2017 | 1355 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 435 | 0.030 |
Why?
|
| HMGB1 Protein | 1 | 2015 | 27 | 0.030 |
Why?
|
| Fasting | 1 | 2016 | 310 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 110 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 1006 | 0.030 |
Why?
|
| Lysosomes | 1 | 2016 | 262 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2018 | 498 | 0.030 |
Why?
|
| Acetylation | 1 | 2015 | 183 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2016 | 486 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 714 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 239 | 0.030 |
Why?
|
| NADPH Oxidase 2 | 1 | 2014 | 41 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2016 | 1046 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2015 | 613 | 0.030 |
Why?
|
| Bile | 1 | 2014 | 47 | 0.030 |
Why?
|
| Species Specificity | 1 | 2015 | 571 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2017 | 349 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 456 | 0.030 |
Why?
|
| Cholestyramine Resin | 1 | 2013 | 13 | 0.030 |
Why?
|
| DNA Primers | 1 | 2015 | 671 | 0.030 |
Why?
|
| NADPH Oxidases | 1 | 2014 | 114 | 0.030 |
Why?
|
| Methylation | 1 | 2014 | 231 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2014 | 123 | 0.030 |
Why?
|
| Caspases | 1 | 2014 | 167 | 0.030 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2014 | 76 | 0.030 |
Why?
|
| Genes, jun | 1 | 2012 | 7 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2017 | 1193 | 0.030 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2012 | 38 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2012 | 62 | 0.020 |
Why?
|
| Genes, myc | 1 | 2012 | 107 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2012 | 86 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2012 | 123 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2012 | 58 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2012 | 67 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2013 | 162 | 0.020 |
Why?
|
| Insulin | 1 | 2017 | 1246 | 0.020 |
Why?
|
| Cholestasis | 1 | 2014 | 158 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 542 | 0.020 |
Why?
|
| Hepatectomy | 1 | 2012 | 124 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2015 | 828 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 1134 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2014 | 432 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 905 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 324 | 0.020 |
Why?
|
| Middle Aged | 1 | 2011 | 29394 | 0.020 |
Why?
|
| Genotype | 1 | 2017 | 2807 | 0.020 |
Why?
|
| Herb-Drug Interactions | 1 | 2010 | 2 | 0.020 |
Why?
|
| Quinolizines | 1 | 2010 | 7 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2010 | 104 | 0.020 |
Why?
|
| Alkaloids | 1 | 2010 | 37 | 0.020 |
Why?
|
| Base Sequence | 1 | 2015 | 3171 | 0.020 |
Why?
|
| Adult | 1 | 2011 | 31946 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1761 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 508 | 0.020 |
Why?
|
| Intestines | 1 | 2013 | 614 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2012 | 1702 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 815 | 0.020 |
Why?
|
| Gene Expression | 1 | 2012 | 1614 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2013 | 729 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 2035 | 0.020 |
Why?
|
| Diet | 1 | 2014 | 1196 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 2837 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2010 | 870 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 6588 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 13011 | 0.010 |
Why?
|